Eli Lilly & co
(LLY) is an American Global pharmaceutical company headquartered in
Indiana, United States. The company does business in a variety of areas that
include:
Lilly Bio Medicines:
this category weighs largest among all in terms of sales. It focuses on
multiple therapeutic areas.
Lilly Diabetes:
This category meets the needs of people who have diabetes and provides them
medicines and support programs. It has also invested in making one of the
largest diabetes pipelines to date.
Elanco Animal health:
The Company works to create and market products that improve the health of
animals and protein production in them. It operates in more than 75 countries.
Emerging Markets:
It employs more than 6000 employees from across 70 countries. This sector has a
lot of growth potential.
Lilly oncology: The
Company is among the top 10 Oncology firms in the world. This category improves
outcomes for individual patients and comes up with innovative products. The
company has one of the largest clinical pipelines in the industry of Oncology.
Eli
Lilly stock price around
13% since the start of 2014 and analysts hold a mean target of $58.50 in the
coming 12 months. Eli Lilly stock is
rated as a hold by analysts.
No comments:
Post a Comment